Growth hormone–releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial
P Koutkia, B Canavan, J Breu, M Torriani, J Kissko… - Jama, 2004 - jamanetwork.com
ContextReduced growth hormone (GH) concentrations are observed in men with human
immunodeficiency virus (HIV) lipodystrophy. ObjectiveTo investigate the effects of growth
hormone–releasing hormone (GHRH), a GH secretagogue, in treatment of HIV
lipodystrophy. Design, Setting, and ParticipantsRandomized, double-blind, placebo-
controlled trial conducted at a research center in the United States between October 2002
and June 2003 and enrolling 31 HIV-infected men aged 18 to 60 years with evidence of …
immunodeficiency virus (HIV) lipodystrophy. ObjectiveTo investigate the effects of growth
hormone–releasing hormone (GHRH), a GH secretagogue, in treatment of HIV
lipodystrophy. Design, Setting, and ParticipantsRandomized, double-blind, placebo-
controlled trial conducted at a research center in the United States between October 2002
and June 2003 and enrolling 31 HIV-infected men aged 18 to 60 years with evidence of …
以上显示的是最相近的搜索结果。 查看全部搜索结果